Startups
By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies. Learn More at NK:IO.
Overview
Location
United Kingdom, England, London
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 25, 2023 | NK:IO Raises £1.2M in Funding | NK:IO, a London, UK-based company which specializes in natural killer (NK) cell biology applied to the development of off-the-shelf cell therapies targeting solid tumours, raised £1.2M in funding. The round, which brought the total amount t... |
| NK:IO | “By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies. Learn More at NK:IO.” |
Reviews 0
FAQ about Cancer Treatment Reimagined
What has the press written about Cancer Treatment Reimagined?
Parsers VC has collected 3 articles mentioning Cancer Treatment Reimagined, among them “NK:IO Raises £1.2M in Funding” (Jul 25, 2023) and “NK:IO”.
Is Cancer Treatment Reimagined still active?
Yes, Cancer Treatment Reimagined is active; its latest activity on Parsers VC dates from Jun 7, 2024.